Midland Wealth Advisors’s AbbVie ABBV Stock Holding History

Midland Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.19M	Sell	12,663 -248	-2%	-$53.4K	0.15%	35
2026 Q1	$2.81M	Sell	12,911 -493	-4%	-$109K	0.14%	36
2025 Q4	$3.06M	Sell	13,404 -1,792	-12%	-$408K	0.16%	34
2025 Q3	$3.52M	Buy	15,196 +1,009	+7%	+$205K	0.19%	34
2025 Q2	$2.63M	Sell	14,187 -110	-0.8%	-$20.4K	0.15%	32
2025 Q1	$3M	Sell	14,297 -1,121	-7%	-$218K	0.18%	30
2024 Q4	$2.74M	Buy	15,418 +45	+0.3%	+$8.27K	0.16%	36
2024 Q3	$3.04M	Sell	15,373 -2,407	-14%	-$449K	0.18%	31
2024 Q2	$3.05M	Buy	17,780 +421	+2%	+$69.7K	0.18%	35
2024 Q1	$3.16M	Buy	17,359 +596	+4%	+$103K	0.19%	29
2023 Q4	$2.6M	Buy	+16,763	New	+$2.44M	0.18%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Midland Wealth Advisors's ABBV Position: Q2 2026 in Review

Midland Wealth Advisors reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $53.4K and leaving 12,663 shares worth $3.19M. The position accounts for 0.15% of the portfolio, ranked #35.

Midland Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.52M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Midland Wealth Advisors held 12,663 shares of AbbVie worth $3.19M as of Q2 2026.
Midland Wealth Advisors sold 248 AbbVie shares in Q2 2026, an estimated $53.4K.
AbbVie made up 0.15% of Midland Wealth Advisors's portfolio in Q2 2026, its #35 holding.
Midland Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Midland Wealth Advisors's AbbVie position peaked at $3.52M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.